BACKGROUND AND OBJECTIVES: Arteriovenous fistulas (AVFs) are the preferred vascular access for hemodialysis but have a considerable failure rate. This study investigated whether routine preoperative vascular ultrasound results in better AVF outcome than physical examination. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with end-stage kidney disease referred for permanent access formation were assessed by independent examiners using physical examination and ultrasound. After random allocation, the ultrasound report was disclosed to the surgeon for patients in the ultrasound group but not for the clinical group. End points were AVF failure and survival rates, analyzed by intention to treat and by use for hemodialysis. RESULTS: AVFs were made in 208 of 218 randomized patients. Clinical and ultrasound groups were similar in terms of patient characteristics, allocation to individual surgeons, and proportion of forearm AVFs. The ultrasound group had a significantly lower rate of immediate failure (4% versus 11%, P = 0.028) and, among failed AVFs, less thrombosis (38% versus 67%, P = 0.029). Primary AVF survival at 1 year was not statistically different (ultrasound = 65%, clinical = 56%, P = 0.081). Assisted primary AVF survival at 1 year was significantly better for the ultrasound group (80% versus 65%, P = 0.012). The number of patients requiring preoperative ultrasound to prevent one AVF failure was 12. CONCLUSIONS:Routine preoperative vascular ultrasound in addition to clinical assessment improves AVF outcomes in terms of patency and use for dialysis. National Research Register, United Kingdom, trial number N0046131432.
RCT Entities:
BACKGROUND AND OBJECTIVES:Arteriovenous fistulas (AVFs) are the preferred vascular access for hemodialysis but have a considerable failure rate. This study investigated whether routine preoperative vascular ultrasound results in better AVF outcome than physical examination. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with end-stage kidney disease referred for permanent access formation were assessed by independent examiners using physical examination and ultrasound. After random allocation, the ultrasound report was disclosed to the surgeon for patients in the ultrasound group but not for the clinical group. End points were AVF failure and survival rates, analyzed by intention to treat and by use for hemodialysis. RESULTS: AVFs were made in 208 of 218 randomized patients. Clinical and ultrasound groups were similar in terms of patient characteristics, allocation to individual surgeons, and proportion of forearm AVFs. The ultrasound group had a significantly lower rate of immediate failure (4% versus 11%, P = 0.028) and, among failed AVFs, less thrombosis (38% versus 67%, P = 0.029). Primary AVF survival at 1 year was not statistically different (ultrasound = 65%, clinical = 56%, P = 0.081). Assisted primary AVF survival at 1 year was significantly better for the ultrasound group (80% versus 65%, P = 0.012). The number of patients requiring preoperative ultrasound to prevent one AVF failure was 12. CONCLUSIONS: Routine preoperative vascular ultrasound in addition to clinical assessment improves AVF outcomes in terms of patency and use for dialysis. National Research Register, United Kingdom, trial number N0046131432.
Authors: Charmaine E Lok; Matthew J Oliver; Jiandong Su; Cynthia Bhola; Neil Hannigan; Sarbjit V Jassal Journal: Kidney Int Date: 2005-06 Impact factor: 10.612
Authors: Young Mi Ku; Young Ok Kim; Ji Il Kim; Yeong Jin Choi; Sun Ae Yoon; Young Soo Kim; Sun Wha Song; Chul Woo Yang; Yong Soo Kim; Yoon Sik Chang; Byung Kee Bang Journal: Nephrol Dial Transplant Date: 2005-10-25 Impact factor: 5.992
Authors: P P G M Rooijens; J H M Tordoir; T Stijnen; J P J Burgmans; A A E A Smet de; T I Yo Journal: Eur J Vasc Endovasc Surg Date: 2004-12 Impact factor: 7.069
Authors: Rita L McGill; Robin Ruthazer; Eduardo Lacson; Klemens B Meyer; Dana C Miskulin; Daniel E Weiner Journal: Hemodial Int Date: 2016-11-20 Impact factor: 1.812
Authors: Esteban Lucas Siga; Noemi Ibalo; Maria R Benegas; Farias Laura; Carlos Luna; David H Aiziczon; Elvio Demicheli Journal: J Bras Nefrol Date: 2019-04-11